Investors and Media

Press Releases

January 23, 2024

Scholar Rock Announces FDA Clearance of IND Application to Initiate Phase 2 Proof-of-Concept Trial with Apitegromab to Treat Obesity

January 12, 2024

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

January 4, 2024

Scholar Rock Provides Corporate Update and Highlights Priorities for 2024

December 19, 2023

Scholar Rock to Present at the 42nd Annual J.P. Morgan Healthcare Conference

December 15, 2023

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

November 17, 2023

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

November 7, 2023

Scholar Rock Reports Third Quarter 2023 Financial Results and Highlights Business Progress

November 3, 2023

Scholar Rock Presents New Data from Phase 1 DRAGON Trial Showing Promising Anti-Tumor Activity in Anti-PD-1 Resistant Metastatic ccRCC Patients and Supporting SRK-181 Continued Tolerability

Archived Press Releases